Cogent Biosciences Inc.

NASDAQ: COGT · Real-Time Price · USD
11.88
0.17 (1.45%)
At close: Aug 15, 2025, 3:59 PM
11.89
0.08%
After-hours: Aug 15, 2025, 05:29 PM EDT

Cogent Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
98.17M 53.23M 139.89M 219.68M
Short-Term Investments
188.91M 212.48M 119.39M n/a
Long-Term Investments
n/a 7.46M n/a 1.25M
Other Long-Term Assets
4.86M 4.86M 4.75M 3.73M
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
9.39M 5.06M 1.25M 2.95M
Total Current Assets
296.47M 270.77M 264.97M 222.63M
Property-Plant & Equipment
26.56M 30.34M 31.1M 4.48M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
31.43M 42.67M 35.84M 9.46M
Total Assets
327.9M 313.44M 300.81M 232.09M
Account Payables
12.01M 10.65M 5.84M 3.48M
Deferred Revenue
n/a n/a 1.7M 7.97M
Short-Term Debt
1.56M n/a 1.42M 2.32M
Other Current Liabilities
40.57M 10.31M 12.1M 5.56M
Total Current Liabilities
55.71M 38.17M 26.85M 17.08M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
15.9M 17.47M 18.23M 831K
Total Liabilities
71.61M 55.63M 45.08M 17.91M
Total Debt
17.47M 18.85M 19.65M 3.15M
Common Stock
110K 86K 70K 44K
Retained Earnings
-859.48M -603.62M -411.21M -270.97M
Comprehensive Income
447K 246K -104K -0.00
Shareholders Equity
256.29M 257.8M 255.74M 214.18M
Total Investments
188.91M 219.94M 119.39M 1.25M